ADNRX — American Beacon ARK Transformational Innovation Fund
Data updated: 2026-08-11
ADNRX — American Beacon ARK Transformational Innovation Fund. Holdings, fees, performance and SEC filings.
ADNRX Fund Overview
ADNRX — American Beacon ARK Transformational Innovation Fund is a US mutual fund managed by American Beacon Funds, categorised as United States Multi-Cap / All-Cap Growth Thematic Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: American Beacon Funds
- Category: United States Multi-Cap / All-Cap Growth Thematic Equity
- Assets under management: $160.02M
- 1-year return: 42.7%
- Ticker: ADNRX
- SEC CIK: 0000809593
- SEC series ID: S000056147
- Share class ID: C000224371
ADNRX Holdings
Top 10 holdings of American Beacon ARK Transformational Innovation Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Tesla Inc | 10.24% |
| American Beacon U.S. Government Money Market | 9.03% |
| Tempus AI Inc | 6.52% |
| Robinhood Markets Inc | 5.86% |
| Advanced Micro Devices Inc | 4.99% |
| CRISPR Therapeutics AG | 4.87% |
| Space Exploration Technologies Corp | 4.57% |
| Shopify Inc | 4.20% |
| Twist Bioscience Corp | 3.95% |
| Coinbase Global Inc | 3.89% |
ADNRX Portfolio Allocation
Asset-class allocation of American Beacon ARK Transformational Innovation Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 9.0% |
ADNRX Performance
Total returns for ADNRX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -11.8% |
| 1 year | 42.7% |
| 3 years (annualised) | 19.1% |
| 5 years (annualised) | -9.9% |
ADNRX Risk Information
Risk metrics for ADNRX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 33.1%
ADNRX Costs and Fees
ADNRX costs about $105 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.05%
- Gross expense ratio: 1.18%
- Portfolio turnover: 46%
- Brokerage commissions: 3.54 bps of average net assets (SEC N-CEN)
ADNRX Cashflows
Over the 12 months to 2026-03, American Beacon ARK Transformational Innovation Fund had net outflows of $61.59M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$4.18M |
| 2026-02 | −$4.64M |
| 2026-01 | −$8.68M |
| 2025-12 | −$4.35M |
| 2025-11 | −$5.10M |
| 2025-10 | −$5.96M |
ADNRX Debt Constituents
No individual debt constituents are reported in American Beacon ARK Transformational Innovation Fund's latest SEC N-PORT filing.
ADNRX Prospectus and SEC Filings
Official American Beacon ARK Transformational Innovation Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Multi-Cap / All-Cap Growth Thematic Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.